HEB Stock Analysis
HEB - Hemispherx BioPharma, Inc listed on AMEX.
HEB - Sector: Healthcare, Industry: Biotechnology and Drugs.
HEB lost -3.70% on 07/28/14.
HEB is trading in the range of $0.26 - $0.35 in the past 30 days.
Commodity Channel Index (CCI) is bullish for HEB.
HEB formed a Doji pattern.
HEB formed a bearish Stochastic Crossdown signal.
Stock performance base on day of week in the past 90 days.
Our rating on the stock: NEUTRAL with a score of 3/5.
HEB Earnings Date